Delivery of two-step transcription amplification exendin-4 plasmid system with arginine-grafted bioreducible polymer in type 2 diabetes animal model
Authors:
- 1 August 2012
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 162 (1) , 9-18
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (013-2011-1-E00060)
- National Institutes of Health (DK077703, WCU 200900000000024)
- National Research Foundation of Korea
This publication has 29 references indexed in Scilit:
- Efficient GLP-1 gene delivery using two-step transcription amplification plasmid system with a secretion signal peptide and arginine-grafted bioreducible polymerJournal of Controlled Release, 2012
- Polymeric Gene Delivery for Diabetic TreatmentDiabetes & Metabolism Journal, 2011
- Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's DiseaseDiabetes, 2009
- Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systemsBiomaterials, 2009
- Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetesExpert Opinion on Investigational Drugs, 2008
- Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1Journal of Clinical Pathology, 2008
- Glucagon-Like Peptide-1 Gene Therapy in Obese Diabetic Mice Results in Long-Term Cure of Diabetes by Improving Insulin Sensitivity and Reducing Hepatic GluconeogenesisDiabetes, 2007
- The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesThe Lancet, 2006
- Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 DiabetesMolecular Therapy, 2005
- Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell ApoptosisJournal of Biological Chemistry, 2003